Ustekinumab trials for Crohn Disease

All Ustekinumab trials · All Crohn Disease trials

Phase breakdown

Recruiting trials studying Ustekinumab for Crohn Disease

• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
  NCT04372108 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
  NCT06520397 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
  NCT05387031 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 8 locations
• Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
  NCT05725876 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
  NCT02103361 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 2 locations

Common questions

How many trials study Ustekinumab for Crohn Disease?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.